Literature DB >> 25496540

LGE patterns in pulmonary hypertension do not impact overall mortality.

Andrew J Swift1, Smitha Rajaram2, Dave Capener2, Charlie Elliot3, Robin Condliffe3, Jim M Wild2, David G Kiely3.   

Abstract

OBJECTIVES: The goal of this study was to determine the prognostic value of late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) features in patients with pulmonary hypertension.
BACKGROUND: The prognostic significance of LGE in the clinical assessment of patients with pulmonary hypertension remains uncertain.
METHODS: Consecutive patients with suspected pulmonary hypertension seen at a specialist pulmonary hypertension referral center who underwent right heart catheterization and CMR with LGE imaging within 48 h were identified. Short-axis late-enhancement imaging was performed using a 3-dimensional gradient spoiled echocardiography sequence on a 1.5-T scanner. Three groups were identified: 1) no late enhancement of the myocardium; 2) late enhancement at the right ventricular insertion points (LGE-IP); and 3) late enhancement involving the right ventricular insertion points and the interventricular septum (LGE-S).
RESULTS: Of 194 patients, 162 had pulmonary hypertension. LGE was identified in 135 of 162 (83%) patients with pulmonary hypertension, and 47 (29%) of patients demonstrated LGE-S. Patients with LGE-S had significantly higher right ventricular end-diastolic volume index (p = 0.013) and lower mixed venous oxygen saturation (p = 0.045) than patients with LGE-IP alone. The presence of LGE-S (p = 0.022), but not LGE-IP alone, right ventricular end-systolic volume (p = 0.045), right ventricular ejection fraction (p = 0.034), mixed venous oxygen saturation (p = 0.021), mean right atrial pressure (0.027), and male sex (p = 0.002) predicted mortality. At multivariate analysis, male sex was the only significant predictor of mortality independent of covariate predictors (p = 0.027).
CONCLUSIONS: The presence of LGE at the right ventricular insertion points is suggestive of the presence of pulmonary hypertension. LGE may also be more extensive, involving the septum; however, after multivariable analysis including other factors associated with pulmonary hypertension, septal LGE was not associated with an increase in overall mortality.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac magnetic resonance; gadolinium; idiopathic pulmonary arterial hypertension; prognosis right ventricle; pulmonary hypertension

Mesh:

Substances:

Year:  2014        PMID: 25496540     DOI: 10.1016/j.jcmg.2014.08.014

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  27 in total

Review 1.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 2.  Assessment of right ventricular function in pulmonary hypertension.

Authors:  Robert Naeije
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

3.  Right Ventricular Fibrosis Is Related to Pulmonary Artery Stiffness in Pulmonary Hypertension: A Cardiac Magnetic Resonance Imaging Study.

Authors:  Matthew Jankowich; Siddique A Abbasi; Alexander Vang; Gaurav Choudhary
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

Review 4.  Traditional and Novel Imaging of Right Ventricular Function in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  C Sciaccaluga; F D'Ascenzi; G E Mandoli; L Rizzo; N Sisti; C Carrucola; P Cameli; E Bigio; S Mondillo; M Cameli
Journal:  Curr Heart Fail Rep       Date:  2020-04

5.  Novel measures of left ventricular electromechanical discoordination predict clinical outcomes in children with pulmonary arterial hypertension.

Authors:  Benjamin S Frank; Michal Schäfer; Johannes M Douwes; D Dunbar Ivy; Steven H Abman; Jesse A Davidson; Sandra Burzlaff; Max B Mitchell; Gareth J Morgan; Lorna P Browne; Alex J Barker; Uyen Truong; Johannes C von Alvensleben
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-12-20       Impact factor: 4.733

Review 6.  Right heart imaging in patients with heart failure: a tale of two ventricles.

Authors:  Myriam Amsallem; Tatiana Kuznetsova; Kate Hanneman; Andre Denault; François Haddad
Journal:  Curr Opin Cardiol       Date:  2016-09       Impact factor: 2.161

7.  Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension.

Authors:  Fritz C Roller; Christoph Wiedenroth; Andreas Breithecker; Christoph Liebetrau; Eckhard Mayer; Christian Schneider; Andreas Rolf; Christian Hamm; Gabriele A Krombach
Journal:  Eur Radiol       Date:  2016-09-20       Impact factor: 5.315

8.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.

Authors:  Tim Lahm; Ivor S Douglas; Stephen L Archer; Harm J Bogaard; Naomi C Chesler; Francois Haddad; Anna R Hemnes; Steven M Kawut; Jeffrey A Kline; Todd M Kolb; Stephen C Mathai; Olaf Mercier; Evangelos D Michelakis; Robert Naeije; Rubin M Tuder; Corey E Ventetuolo; Antoine Vieillard-Baron; Norbert F Voelkel; Anton Vonk-Noordegraaf; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

Review 9.  Contrast - in cardiac magnetic resonance imaging.

Authors:  Nirav Patel; Pavani Kolakalapudi; Garima Arora
Journal:  Echocardiography       Date:  2018-02-23       Impact factor: 1.724

10.  Does Late Gadolinium Enhancement still have Value? Right Ventricular Internal Mechanical Work, Ea/Emax and Late Gadolinium Enhancement as Prognostic Markers in Patients with Advanced Pulmonary Hypertension via Cardiac MRI.

Authors:  Amr Ei Abouelnour; Mark Doyle; Diane V Thompson; June Yamrozik; Ronald B Williams; Moneal B Shah; Siva Kr Soma; Srinivas Murali; Raymond L Benza; Robert Ww Biederman
Journal:  Cardiol Res Cardiovasc Med       Date:  2017-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.